{"id":2327,"date":"2022-11-02T09:41:30","date_gmt":"2022-11-02T09:41:30","guid":{"rendered":"https:\/\/rheuma.dev-test.link\/?page_id=2327"},"modified":"2023-02-07T07:54:04","modified_gmt":"2023-02-07T07:54:04","slug":"%ce%b4%ce%b9%ce%b1%cf%84%cf%81%ce%b9%ce%b2%ce%ad%cf%82-%cf%80%ce%bf%cf%85-%ce%b5%ce%ba%cf%80%ce%bf%ce%bd%ce%ae%ce%b8%ce%b7%ce%ba%ce%b1%ce%bd-%cf%83%cf%84%ce%b7%ce%bd-%cf%81%ce%b5%cf%85%ce%bc%ce%b1","status":"publish","type":"page","link":"https:\/\/rheumatology.gr\/en\/%ce%b4%ce%b9%ce%b1%cf%84%cf%81%ce%b9%ce%b2%ce%ad%cf%82-%cf%80%ce%bf%cf%85-%ce%b5%ce%ba%cf%80%ce%bf%ce%bd%ce%ae%ce%b8%ce%b7%ce%ba%ce%b1%ce%bd-%cf%83%cf%84%ce%b7%ce%bd-%cf%81%ce%b5%cf%85%ce%bc%ce%b1\/","title":{"rendered":"PhD Thesis which have been developed in Rheumatology Clinic<\/strong>"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

\u0394\u03b9\u03b1\u03c4\u03c1\u03b9\u03b2\u03ad\u03c2 \u03c0\u03bf\u03c5 \u03b5\u03ba\u03c0\u03bf\u03bd\u03ae\u03b8\u03b7\u03ba\u03b1\u03bd \u03c3\u03c4\u03b7\u03bd \u03a1\u03b5\u03c5\u03bc\u03b1\u03c4\u03bf\u03ba\u03bf\u03b3\u03b9\u03ba\u03ae \u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ae<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u0392\u03bf\u03cd\u03bb\u03b3\u03b1\u03c1\u03b7 \u03a0\u03b1\u03c1\u03b1\u03c3\u03ba\u03b5\u03c5\u03ae:<\/strong> \u0391\u03bd\u03b1\u03b9\u03bc\u03af\u03b1 \u03ba\u03b1\u03b9 \u03c1\u03b5\u03c5\u03bc\u03b1\u03c4\u03bf\u03b5\u03b9\u03b4\u03ae\u03c2 \u03b1\u03c1\u03b8\u03c1\u03af\u03c4\u03b9\u03b4\u03b1
(18-6-1998).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Publication:<\/p>

Voulgari PV<\/u>, Kolios G, Papadopoulos GK, Katsaraki A, Seferiadis K, Drosos AA: Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis. Clin Immunol 92: 153-160, 1999.<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u03a7\u03b1\u03c4\u03b6\u03b7\u03c0\u03ad\u03c4\u03c1\u03bf\u03c5 \u03a0\u03ad\u03c4\u03c1\u03bf\u03c2:<\/strong> \u039c\u03b5\u03bb\u03ad\u03c4\u03b7 \u03b1\u03c5\u03c4\u03bf\u03b1\u03bd\u03c4\u03b9\u03c3\u03c9\u03bc\u03ac\u03c4\u03c9\u03bd \u03c3\u03b5 \u03b4\u03b9\u03ac\u03c6\u03bf\u03c1\u03b5\u03c2 \u03b7\u03bb\u03b9\u03ba\u03b9\u03b1\u03ba\u03ad\u03c2 \u03bf\u03bc\u03ac\u03b4\u03b5\u03c2 \u03c5\u03b3\u03b9\u03ce\u03bd \u03b3\u03c5\u03bd\u03b1\u03b9\u03ba\u03ce\u03bd (17-11-1998).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Publication:<\/p>

Mavridis AK, Ming KX, Hatzipetrou P<\/u>, Papanikolaou NG, Tzioufas AG, Moutsopoulos HM: Prevalence of non-organ-specific autoantibodies in pregnant and non-pregnant healthy women. Lupus 1: 141-144, 1992.<\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u03a3\u03b1\u03ba\u03ba\u03ac \u0392\u03b1\u0390\u03b1:<\/strong> \u03a3\u03c5\u03c3\u03c4\u03b7\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c2 \u03b5\u03c1\u03c5\u03b8\u03b7\u03bc\u03b1\u03c4\u03ce\u03b4\u03b7\u03c2 \u03bb\u03cd\u03ba\u03bf\u03c2 \u03ba\u03b1\u03b9 \u03ba\u03cd\u03b7\u03c3\u03b7 (13-12-2002).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Publication:<\/p>

Georgiou PE, Politi EN, Katsimbri P, Sakka V<\/u>, Drosos AA: Outcome of lupus pregnancy: a controlled study. Rheumatology 39: 1014-1019, 2000.<\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u03a0\u03b1\u03c0\u03b1\u03b4\u03cc\u03c0\u03bf\u03c5\u03bb\u03bf\u03c2 \u0399\u03c9\u03ac\u03bd\u03bd\u03b7\u03c2:<\/strong> \u03a1\u03b5\u03c5\u03bc\u03b1\u03c4\u03bf\u03b5\u03b9\u03b4\u03ae\u03c2 \u03b1\u03c1\u03b8\u03c1\u03af\u03c4\u03b9\u03b4\u03b1 \u03ba\u03b1\u03b9 \u03c5\u03c0\u03bf\u03ba\u03b1\u03c4\u03b7\u03b3\u03bf\u03c1\u03af\u03b5\u03c2 \u03b1\u03c5\u03c4\u03ae\u03c2 (2-6-2004).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Publication:<\/p>

  • Papadopoulos IA<\/u>, Katsimbri P, Katsaraki A, Temekonidis T, Georgiadis A, Drosos AA. Clinical course and outcome of early rheumatoid arthritis. Rheumatol Int 20: 205-210, 2001.<\/div><\/li>
  • Papadopoulos IA<\/u> , Katsimbri P, Alamanos Y, Voulgari PV, Drosos AA: Early rheumatoid arthritis patients: relationship of age. Rheumatol Int 23: 70-74, 2003.<\/div><\/li>
  • Voulgari PV, Papadopoulos IA<\/u>, Alamanos Y, Katsaraki A, Drosos AA: Early rheumatoid arthritis: does gender influence disease expression? Clin Exp Rheumatol 22: 165-170, 2004.<\/div><\/li><\/ul><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t

    \u03a0\u03b1\u03c0\u03b1\u03b4\u03cc\u03c0\u03bf\u03c5\u03bb\u03bf\u03c2 \u039d\u03b9\u03ba\u03cc\u03bb\u03b1\u03bf\u03c2:<\/strong> \u03a3\u03c5\u03c3\u03c7\u03ad\u03c4\u03b9\u03c3\u03b7 \u03c4\u03bf\u03c5 \u03ba\u03b1\u03c0\u03bd\u03af\u03c3\u03bc\u03b1\u03c4\u03bf\u03c2 \u03bc\u03b5 \u03c4\u03b7 \u03c3\u03c5\u03c7\u03bd\u03cc\u03c4\u03b7\u03c4\u03b1 \u03ba\u03b1\u03b9 \u03c4\u03b7 \u03b2\u03b1\u03c1\u03cd\u03c4\u03b7\u03c4\u03b1 \u03c4\u03b7\u03c2 \u03c1\u03b5\u03c5\u03bc\u03b1\u03c4\u03bf\u03b5\u03b9\u03b4\u03bf\u03cd\u03c2 \u03b1\u03c1\u03b8\u03c1\u03af\u03c4\u03b9\u03b4\u03b1\u03c2 (6-2-2006).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t

    Publication:<\/p>

    Papadopoulos NG<\/u>, Alamanos Y, Voulgari PV, Epagelis EK, Tsifetaki N, Drosos AA: Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients? Clin Exp Rheumatol 23: 861-866, 2005.<\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t

    \u03a4\u03c3\u03b9\u03c6\u03b5\u03c4\u03ac\u03ba\u03b7 \u039d\u03af\u03ba\u03b7:<\/strong> \u03a0\u03c1\u03bf\u03bf\u03b4\u03b5\u03c5\u03c4\u03b9\u03ba\u03ae \u03c3\u03c5\u03c3\u03c4\u03b7\u03bc\u03b1\u03c4\u03b9\u03ba\u03ae \u03c3\u03ba\u03bb\u03ae\u03c1\u03c5\u03bd\u03c3\u03b7 (\u03c3\u03ba\u03bb\u03b7\u03c1\u03cc\u03b4\u03b5\u03c1\u03bc\u03b1) (3-3-2006).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t

    Publication:<\/p>

    • Alamanos Y, Tsifetaki N<\/u>, Voulgari PV, Siozos C, Tsamandouraki K, Alexiou GA, Drosos AA. Epidemiology of systemic sclerosis in northwest Greece 1981 to 2002. Semin Arthritis Rheum 34: 714-720, 2005.<\/div><\/li>
    • Argyropoulou MI, Tsifetaki N<\/u>, Zikou AK, Xydis V, Venestanopoulou AI, Margariti P, Drosos AA. Systemic sclerosis: brain abnormalities revealed by conventional magnetic resonance imaging and magnetization transfer imaging. Arthritis Rheum 54: 1350-1352, 2006.<\/div><\/li>
    • Hyphantis TN , Tsifetaki N<\/u>, Pappa C, Voulgari PV, Siafaka V, Bai M, Alamanos Y, Drosos AA, Mavreas V. Clinical features and personality traits associated with psychological distress in systemic sclerosis patients. J Psychosom Res 62: 47-56 , 2007.<\/div><\/li><\/ul><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
      \n\t\t\t\t\t\t
      \n\t\t\t\t\t
      \n\t\t\t
      \n\t\t\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t\t\t\t\t

      \u0393\u03b5\u03c9\u03c1\u03b3\u03b9\u03ac\u03b4\u03b7\u03c2 \u0391\u03b8\u03b1\u03bd\u03ac\u03c3\u03b9\u03bf\u03c2:<\/strong> \u0394\u03c5\u03c3\u03bb\u03b9\u03c0\u03b9\u03b4\u03b1\u03b9\u03bc\u03af\u03b1 \u03c3\u03b5 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u03c0\u03c1\u03ce\u03b9\u03bc\u03b7 \u03c1\u03b5\u03c5\u03bc\u03b1\u03c4\u03bf\u03b5\u03b9\u03b4\u03ae \u03b1\u03c1\u03b8\u03c1\u03af\u03c4\u03b9\u03b4\u03b1 (7-6-2006).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

      \n\t\t\t\t
      \n\t\t\t\t\t\t\t\t\t

      Publication:<\/p>

      Georgiadis AN<\/u>, Papavasiliou EC, Lourida ES, Alamanos Y, Kostara C, Tselepis AD, Drosos AA. Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment–a prospective, controlled study. Arthritis Res Ther 8: R82, 2006.<\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
      \n\t\t\t
      \n\t\t\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t\t\t\t\t

      \u039a\u03af\u03c3\u03c4\u03b7\u03c2 \u039a\u03c9\u03bd\u03c3\u03c4\u03b1\u03bd\u03c4\u03af\u03bd\u03bf\u03c2:<\/strong> \u0391\u03bd\u03c4\u03b9\u03c3\u03ce\u03bc\u03b1\u03c4\u03b1 \u03b1\u03bd\u03c4\u03b9-Ro(SSA) \u03c3\u03c4\u03b7 \u03c1\u03b5\u03c5\u03bc\u03b1\u03c4\u03bf\u03b5\u03b9\u03b4\u03ae \u03b1\u03c1\u03b8\u03c1\u03af\u03c4\u03b9\u03b4\u03b1. \u0391\u03bd\u03bf\u03c3\u03bf\u03bb\u03bf\u03b3\u03b9\u03ba\u03ae \u03b1\u03c0\u03cc\u03ba\u03c1\u03b9\u03c3\u03b7 \u03ba\u03b1\u03c4\u03ac \u03bc\u03b7 \u03b4\u03b9\u03b1\u03c4\u03b7\u03c1\u03b7\u03bc\u03ad\u03bd\u03c9\u03bd \u03b5\u03c0\u03b9\u03c4\u03cc\u03c0\u03c9\u03bd (15-9-2006).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

      \n\t\t\t\t
      \n\t\t\t\t\t\t\t\t\t

      Publication:<\/p>

      • Manoussakis MN, Kistis KG<\/u>, Liu X, Aidinis V, Guialis A, Moutsopoulos HM. Detection of anti-Ro(SSA) antibodies in autoimmune diseases: comparison of five methods. Br J Rheumatol 32: 449-455, 1993.<\/div><\/li>
      • Manoussakis MN, Kistis CG<\/u>, Aidinis V, Guialis A, Piha L, Sekeris CE, Moutsopoulos HM: Detection of human-specific anti-la(SSB) antibodies in patients with rheumatoid arthritis. J Autoimmun 8: 959-969, 1995.<\/div><\/li><\/ul><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
        \n\t\t\t
        \n\t\t\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t

        \u039c\u03b1\u03c1\u03ba\u03b1\u03c4\u03c3\u03ad\u03bb\u03b7 \u0398\u03b5\u03bf\u03b4\u03ce\u03c1\u03b1:<\/strong> \u039a\u03b1\u03c4\u03b1\u03c3\u03c4\u03c1\u03bf\u03c6\u03ae \u03c0\u03b5\u03c1\u03b9\u03c6\u03b5\u03c1\u03b9\u03ba\u03ce\u03bd \u03b1\u03c1\u03b8\u03c1\u03ce\u03c3\u03b5\u03c9\u03bd \u03c3\u03c4\u03b7 \u03c1\u03b5\u03c5\u03bc\u03b1\u03c4\u03bf\u03b5\u03b9\u03b4\u03ae \u03b1\u03c1\u03b8\u03c1\u03af\u03c4\u03b9\u03b4\u03b1 \u2013 \u03c0\u03c1\u03bf\u03b3\u03bd\u03c9\u03c3\u03c4\u03b9\u03ba\u03bf\u03af \u03b4\u03b5\u03af\u03ba\u03c4\u03b5\u03c2 (23-12-2009).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

        \n\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t

        Publication:<\/p>

        • Markatseli TE<\/u>, Papagoras C, Drosos AA. Prognostic factors for erosive rheumatoid arthritis. Clin Exp Rheumatol 28: 114-23, 2010.<\/div><\/li>
        • Markatseli TE<\/u>, Voulgari PV, Alamanos Y, Drosos AA. Prognostic Factors of Radiological Damage in Rheumatoid Arthritis: A 10-year Retrospective Study. J Rheumatol 38: 44-52, 2011.<\/div><\/li><\/ul><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
          \n\t\t\t\t\t\t
          \n\t\t\t\t\t
          \n\t\t\t
          \n\t\t\t\t\t\t
          \n\t\t\t\t
          \n\t\t\t\t\t\t\t\t\t

          \u03a3\u03b1\u03bf\u03cd\u03b3\u03ba\u03bf\u03c5 \u0399\u03c9\u03ac\u03bd\u03bd\u03b1:<\/strong> \u039c\u03b5\u03bb\u03ad\u03c4\u03b7 \u03c6\u03bb\u03b5\u03b3\u03bc\u03bf\u03bd\u03c9\u03b4\u03ce\u03bd \u03c3\u03c0\u03bf\u03bd\u03b4\u03c5\u03bb\u03bf\u03b1\u03c1\u03b8\u03c1\u03bf\u03c0\u03b1-\u03b8\u03b5\u03b9\u03ce\u03bd (4-2-2011).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

          \n\t\t\t\t
          \n\t\t\t\t\t\t\t\t\t

          Publication:<\/p>

          • Paschou S, Voulgari PV, Vrabie IG, Saougou IG<\/u>, Drosos AA. Fertility and reproduction in male patients with ankylosing spondylitis treated with infliximab. J Rheumatol 36: 351-354, 2009.<\/div><\/li>
          • Saougou I<\/u>, Markatseli TE, Voulgari PV, Drosos AA. Maintained clinical response of infliximab treatment in ankylosing spondylitis: a 6-year long-term study. Joint Bone Spine 77: 325-9, 2010.<\/div><\/li>
          • Saougou I<\/u>, Papagoras C, Markatseli TE, Voulgari PV, Drosos AA. A case report of a psoriatic arthritis patient on hemodialysis treated with tumor necrosis factor blocking agent and a literature review. Clin Rheumatol 29: 1455-1459, 2010.<\/div><\/li>
          • Saougou I<\/u>, Markatseli TE, Papagoras C, Voulgari PV, Alamanos Y, Drosos AA. Sustained Clinical Response in Psoriatic Arthritis Patients Treated with Anti-TNF Agents: A 5-year Open-Label Observational Cohort Study. Semin Arthritis Rheum 2010 Sep 14.<\/div><\/li><\/ul><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
            \n\t\t\t
            \n\t\t\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t\t\t\t\t\t

            \u03a0\u03b1\u03c0\u03b1\u03b3\u03cc\u03c1\u03b1\u03c2 \u03a7\u03b1\u03c1\u03ac\u03bb\u03b1\u03bc\u03c0\u03bf\u03c2:<\/strong> \u039a\u03b1\u03c1\u03b4\u03b9\u03b1\u03b3\u03b3\u03b5\u03b9\u03b1\u03ba\u03cc\u03c2 \u03ba\u03af\u03bd\u03b4\u03c5\u03bd\u03bf\u03c2 \u03c3\u03b5 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u03c3\u03c0\u03bf\u03bd\u03b4\u03c5\u03bb\u03bf\u03b1\u03c1\u03b8\u03c1\u03bf\u03c0\u03ac\u03b8\u03b5\u03b9\u03b5\u03c2 (20-2-2013).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

            \n\t\t\t\t
            \n\t\t\t\t\t\t\t\t\t

            Publication:<\/p>

            • Papagoras C<\/u>, Drosos AA: Seronegative spondyloarthropathies: evolving concepts regarding diagnosis and treatment. J Spine 1: 1000e102, 2012.<\/div><\/li>
            • Drosos AA, Papagoras C<\/u>: Cardiovascular disease in ankylosing spondylitis: another extra-skeletal feature of a chronic inflammatory disorder? J Spine 1: 1000e106, 2012.<\/div><\/li>
            • Papagoras C<\/u>, Voulgari PV, Drosos AA: Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis. Clin Exp Rheumatol 2013 Feb 7. [Epub ahead of print].<\/div><\/li>
            • Papagoras C<\/u>, Markatseli TE, Saougou I, Alamanos Y, Zikou AK, Voulgari PV, Kiortsis DN, Drosos AA: Cardiovascular risk profile in patients with spondyloarthritis. Joint Bone Spine (in press) 2013.<\/div><\/li><\/ul><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
              \n\t\t\t
              \n\t\t\t\t\t\t
              \n\t\t\t\t
              \n\t\t\t\t\t\t\t\t\t

              \u0395\u03c5\u03c1\u03b9\u03c0\u03af\u03b4\u03b7\u03c2 \u039a\u03b1\u03bb\u03c4\u03c3\u03bf\u03bd\u03bf\u03cd\u03b4\u03b7\u03c2:<\/strong> \u039d\u03b5\u03c5\u03c1\u03bf\u03bb\u03bf\u03b3\u03b9\u03ba\u03ad\u03c2 \u03b5\u03ba\u03b4\u03b7\u03bb\u03ce\u03c3\u03b5\u03b9\u03c2 \u03c4\u03c9\u03bd
              \u03b1\u03bd\u03c4\u03b9-TNF-\u03b1 \u03c0\u03b1\u03c1\u03b1\u03b3\u03cc\u03bd\u03c4\u03c9\u03bd \u03c3\u03b5 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u03c1\u03b5\u03c5\u03bc\u03b1\u03c4\u03bf\u03bb\u03bf\u03b3\u03b9\u03ba\u03ac \u03bd\u03bf\u03c3\u03ae\u03bc\u03b1\u03c4\u03b1 (15-12-2014).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

              \n\t\t\t\t
              \n\t\t\t\t\t\t\t\t\t

              Publication:<\/p>

              • Kaltsonoudis E<\/u>, Voulgari PV, Konitsiotis S, Drosos AA: Demyelination and other neurological adverse events after anti-TNF therapy. Autoimmun Rev 13: 54-58, 2014.<\/div><\/li>
              • Kaltsonoudis E<\/u>, Zikou AK, Voulgari PV, Konitsiotis S, Argyropoulou MI, Drosos AA.Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study. Arthritis Res Ther 16: R125, 2014.<\/div><\/li><\/ul><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
                \n\t\t\t\t\t\t
                \n\t\t\t\t\t
                \n\t\t\t
                \n\t\t\t\t\t\t
                \n\t\t\t\t
                \n\t\t\t\t\t\t\t\t\t

                \u039c\u03b9\u03c7\u03b1\u03ae\u03bb \u039c\u03af\u03b3\u03ba\u03bf\u03c2 <\/strong>(11-09-2017).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

                \n\t\t\t
                \n\t\t\t\t\t\t
                \n\t\t\t\t
                \n\t\t\t\t\t\t\t\t\t

                \u03a0\u03b1\u03bd\u03b1\u03b3\u03b9\u03ce\u03c4\u03b7\u03c2 \u039c\u03c0\u03cc\u03b6\u03b9\u03bf\u03c2<\/strong> (14-09-2017).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

                \n\t\t\t
                \n\t\t\t\t\t\t
                \n\t\t\t\t
                \n\t\t\t\t\t\t\t\t\t

                \u03a7\u03c1\u03ae\u03c3\u03c4\u03bf\u03c2 \u03a0\u03b1\u03c0\u03b1\u03b4\u03cc\u03c0\u03bf\u03c5\u03bb\u03bf\u03c2 <\/strong>(21-09-2017).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

                \n\t\t\t\t\t\t
                \n\t\t\t\t\t
                \n\t\t\t
                \n\t\t\t\t\t\t
                \n\t\t\t\t
                \n\t\t\t\t\t\t\t\t\t

                \u0391\u03bb\u03af\u03ba\u03b7 \u0392\u03b5\u03bd\u03b5\u03c4\u03c3\u03b1\u03bd\u03bf\u03c0\u03bf\u03cd\u03bb\u03bf\u03c5\u00a0<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

                \n\t\t\t
                \n\t\t\t\t\t\t
                \n\t\t\t\t
                \n\t\t\t\t\t\t\t\t\t

                \u03a0\u03b1\u03c0\u03b1\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb \u0393\u03b5\u03ce\u03c1\u03b3\u03b9\u03bf\u03c2<\/strong>\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

                \n\t\t\t
                \n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

                \u0394\u03b9\u03b1\u03c4\u03c1\u03b9\u03b2\u03ad\u03c2 \u03c0\u03bf\u03c5 \u03b5\u03ba\u03c0\u03bf\u03bd\u03ae\u03b8\u03b7\u03ba\u03b1\u03bd \u03c3\u03c4\u03b7\u03bd \u03a1\u03b5\u03c5\u03bc\u03b1\u03c4\u03bf\u03ba\u03bf\u03b3\u03b9\u03ba\u03ae \u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ae \u0392\u03bf\u03cd\u03bb\u03b3\u03b1\u03c1\u03b7 \u03a0\u03b1\u03c1\u03b1\u03c3\u03ba\u03b5\u03c5\u03ae: \u0391\u03bd\u03b1\u03b9\u03bc\u03af\u03b1 \u03ba\u03b1\u03b9 \u03c1\u03b5\u03c5\u03bc\u03b1\u03c4\u03bf\u03b5\u03b9\u03b4\u03ae\u03c2 \u03b1\u03c1\u03b8\u03c1\u03af\u03c4\u03b9\u03b4\u03b1 (18-6-1998). Publication: Voulgari PV, Kolios G, Papadopoulos GK, Katsaraki A, Seferiadis K, Drosos AA: Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis. Clin Immunol 92: 153-160, 1999. \u03a7\u03b1\u03c4\u03b6\u03b7\u03c0\u03ad\u03c4\u03c1\u03bf\u03c5 \u03a0\u03ad\u03c4\u03c1\u03bf\u03c2: \u039c\u03b5\u03bb\u03ad\u03c4\u03b7 \u03b1\u03c5\u03c4\u03bf\u03b1\u03bd\u03c4\u03b9\u03c3\u03c9\u03bc\u03ac\u03c4\u03c9\u03bd \u03c3\u03b5 \u03b4\u03b9\u03ac\u03c6\u03bf\u03c1\u03b5\u03c2 \u03b7\u03bb\u03b9\u03ba\u03b9\u03b1\u03ba\u03ad\u03c2 \u03bf\u03bc\u03ac\u03b4\u03b5\u03c2 \u03c5\u03b3\u03b9\u03ce\u03bd \u03b3\u03c5\u03bd\u03b1\u03b9\u03ba\u03ce\u03bd (17-11-1998). Publication: Mavridis AK, Ming KX, Hatzipetrou P, Papanikolaou NG, Tzioufas AG, Moutsopoulos HM: Prevalence of non-organ-specific autoantibodies in pregnant and non-pregnant healthy women. Lupus 1: 141-144, 1992. \u03a3\u03b1\u03ba\u03ba\u03ac \u0392\u03b1\u0390\u03b1: \u03a3\u03c5\u03c3\u03c4\u03b7\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c2 \u03b5\u03c1\u03c5\u03b8\u03b7\u03bc\u03b1\u03c4\u03ce\u03b4\u03b7\u03c2 \u03bb\u03cd\u03ba\u03bf\u03c2 \u03ba\u03b1\u03b9 \u03ba\u03cd\u03b7\u03c3\u03b7 (13-12-2002). Publication: Georgiou PE, Politi EN, Katsimbri P, Sakka V, Drosos AA: Outcome of lupus pregnancy: a controlled study. Rheumatology 39: 1014-1019, 2000. \u03a0\u03b1\u03c0\u03b1\u03b4\u03cc\u03c0\u03bf\u03c5\u03bb\u03bf\u03c2 \u0399\u03c9\u03ac\u03bd\u03bd\u03b7\u03c2: \u03a1\u03b5\u03c5\u03bc\u03b1\u03c4\u03bf\u03b5\u03b9\u03b4\u03ae\u03c2 \u03b1\u03c1\u03b8\u03c1\u03af\u03c4\u03b9\u03b4\u03b1 \u03ba\u03b1\u03b9 \u03c5\u03c0\u03bf\u03ba\u03b1\u03c4\u03b7\u03b3\u03bf\u03c1\u03af\u03b5\u03c2 \u03b1\u03c5\u03c4\u03ae\u03c2 (2-6-2004). Publication: Papadopoulos IA, Katsimbri P, Katsaraki A, Temekonidis T, Georgiadis A, Drosos AA. Clinical course and outcome of early rheumatoid arthritis. Rheumatol Int 20: 205-210, 2001. Papadopoulos IA , Katsimbri P, Alamanos Y, Voulgari PV, Drosos AA: Early rheumatoid arthritis patients: relationship of age. Rheumatol Int 23: 70-74, 2003. Voulgari PV, Papadopoulos IA, Alamanos Y, Katsaraki A, Drosos AA: Early rheumatoid arthritis: does gender influence disease expression? Clin Exp Rheumatol 22: 165-170, 2004. \u03a0\u03b1\u03c0\u03b1\u03b4\u03cc\u03c0\u03bf\u03c5\u03bb\u03bf\u03c2 \u039d\u03b9\u03ba\u03cc\u03bb\u03b1\u03bf\u03c2: \u03a3\u03c5\u03c3\u03c7\u03ad\u03c4\u03b9\u03c3\u03b7 \u03c4\u03bf\u03c5 \u03ba\u03b1\u03c0\u03bd\u03af\u03c3\u03bc\u03b1\u03c4\u03bf\u03c2 \u03bc\u03b5 \u03c4\u03b7 \u03c3\u03c5\u03c7\u03bd\u03cc\u03c4\u03b7\u03c4\u03b1 \u03ba\u03b1\u03b9 \u03c4\u03b7 \u03b2\u03b1\u03c1\u03cd\u03c4\u03b7\u03c4\u03b1 \u03c4\u03b7\u03c2 \u03c1\u03b5\u03c5\u03bc\u03b1\u03c4\u03bf\u03b5\u03b9\u03b4\u03bf\u03cd\u03c2 \u03b1\u03c1\u03b8\u03c1\u03af\u03c4\u03b9\u03b4\u03b1\u03c2 (6-2-2006). Publication: Papadopoulos NG, Alamanos Y, Voulgari PV, Epagelis EK, Tsifetaki N, Drosos AA: Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients? Clin Exp Rheumatol 23: 861-866, 2005. \u03a4\u03c3\u03b9\u03c6\u03b5\u03c4\u03ac\u03ba\u03b7 \u039d\u03af\u03ba\u03b7: \u03a0\u03c1\u03bf\u03bf\u03b4\u03b5\u03c5\u03c4\u03b9\u03ba\u03ae \u03c3\u03c5\u03c3\u03c4\u03b7\u03bc\u03b1\u03c4\u03b9\u03ba\u03ae \u03c3\u03ba\u03bb\u03ae\u03c1\u03c5\u03bd\u03c3\u03b7 (\u03c3\u03ba\u03bb\u03b7\u03c1\u03cc\u03b4\u03b5\u03c1\u03bc\u03b1) (3-3-2006). Publication: Alamanos Y, Tsifetaki N, Voulgari PV, Siozos C, Tsamandouraki K, Alexiou GA, Drosos AA. Epidemiology of systemic sclerosis in northwest Greece 1981 to 2002. Semin Arthritis Rheum 34: 714-720, 2005. Argyropoulou MI, Tsifetaki N, Zikou AK, Xydis V, Venestanopoulou AI, Margariti P, Drosos AA. Systemic sclerosis: brain abnormalities revealed by conventional magnetic resonance imaging and magnetization transfer imaging. Arthritis Rheum 54: 1350-1352, 2006. Hyphantis TN , Tsifetaki N, Pappa C, Voulgari PV, Siafaka V, Bai M, Alamanos Y, Drosos AA, Mavreas V. Clinical features and personality traits associated with psychological distress in systemic sclerosis patients. J Psychosom Res 62: 47-56 , 2007. \u0393\u03b5\u03c9\u03c1\u03b3\u03b9\u03ac\u03b4\u03b7\u03c2 \u0391\u03b8\u03b1\u03bd\u03ac\u03c3\u03b9\u03bf\u03c2: \u0394\u03c5\u03c3\u03bb\u03b9\u03c0\u03b9\u03b4\u03b1\u03b9\u03bc\u03af\u03b1 \u03c3\u03b5 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u03c0\u03c1\u03ce\u03b9\u03bc\u03b7 \u03c1\u03b5\u03c5\u03bc\u03b1\u03c4\u03bf\u03b5\u03b9\u03b4\u03ae \u03b1\u03c1\u03b8\u03c1\u03af\u03c4\u03b9\u03b4\u03b1 (7-6-2006). Publication: Georgiadis AN, Papavasiliou EC, Lourida ES, Alamanos Y, Kostara C, Tselepis AD, Drosos AA. Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment–a prospective, controlled study. Arthritis Res Ther 8: R82, 2006. \u039a\u03af\u03c3\u03c4\u03b7\u03c2 \u039a\u03c9\u03bd\u03c3\u03c4\u03b1\u03bd\u03c4\u03af\u03bd\u03bf\u03c2: \u0391\u03bd\u03c4\u03b9\u03c3\u03ce\u03bc\u03b1\u03c4\u03b1 \u03b1\u03bd\u03c4\u03b9-Ro(SSA) \u03c3\u03c4\u03b7 \u03c1\u03b5\u03c5\u03bc\u03b1\u03c4\u03bf\u03b5\u03b9\u03b4\u03ae \u03b1\u03c1\u03b8\u03c1\u03af\u03c4\u03b9\u03b4\u03b1. \u0391\u03bd\u03bf\u03c3\u03bf\u03bb\u03bf\u03b3\u03b9\u03ba\u03ae \u03b1\u03c0\u03cc\u03ba\u03c1\u03b9\u03c3\u03b7 \u03ba\u03b1\u03c4\u03ac \u03bc\u03b7 \u03b4\u03b9\u03b1\u03c4\u03b7\u03c1\u03b7\u03bc\u03ad\u03bd\u03c9\u03bd \u03b5\u03c0\u03b9\u03c4\u03cc\u03c0\u03c9\u03bd (15-9-2006). Publication: Manoussakis MN, Kistis KG, Liu X, Aidinis V, Guialis A, Moutsopoulos HM. Detection of anti-Ro(SSA) antibodies in autoimmune diseases: comparison of five methods. Br J Rheumatol 32: 449-455, 1993. Manoussakis MN, Kistis CG, Aidinis V, Guialis A, Piha L, Sekeris CE, Moutsopoulos HM: Detection of human-specific anti-la(SSB) antibodies in patients with rheumatoid arthritis. J Autoimmun 8: 959-969, 1995. \u039c\u03b1\u03c1\u03ba\u03b1\u03c4\u03c3\u03ad\u03bb\u03b7 \u0398\u03b5\u03bf\u03b4\u03ce\u03c1\u03b1: \u039a\u03b1\u03c4\u03b1\u03c3\u03c4\u03c1\u03bf\u03c6\u03ae \u03c0\u03b5\u03c1\u03b9\u03c6\u03b5\u03c1\u03b9\u03ba\u03ce\u03bd \u03b1\u03c1\u03b8\u03c1\u03ce\u03c3\u03b5\u03c9\u03bd \u03c3\u03c4\u03b7 \u03c1\u03b5\u03c5\u03bc\u03b1\u03c4\u03bf\u03b5\u03b9\u03b4\u03ae \u03b1\u03c1\u03b8\u03c1\u03af\u03c4\u03b9\u03b4\u03b1 \u2013 \u03c0\u03c1\u03bf\u03b3\u03bd\u03c9\u03c3\u03c4\u03b9\u03ba\u03bf\u03af \u03b4\u03b5\u03af\u03ba\u03c4\u03b5\u03c2 (23-12-2009). Publication: Markatseli TE, Papagoras C, Drosos AA. Prognostic factors for erosive rheumatoid arthritis. Clin Exp Rheumatol 28: 114-23, 2010. Markatseli TE, Voulgari PV, Alamanos Y, Drosos AA. Prognostic Factors of Radiological Damage in Rheumatoid Arthritis: A 10-year Retrospective Study. J Rheumatol 38: 44-52, 2011. \u03a3\u03b1\u03bf\u03cd\u03b3\u03ba\u03bf\u03c5 \u0399\u03c9\u03ac\u03bd\u03bd\u03b1: \u039c\u03b5\u03bb\u03ad\u03c4\u03b7 \u03c6\u03bb\u03b5\u03b3\u03bc\u03bf\u03bd\u03c9\u03b4\u03ce\u03bd \u03c3\u03c0\u03bf\u03bd\u03b4\u03c5\u03bb\u03bf\u03b1\u03c1\u03b8\u03c1\u03bf\u03c0\u03b1-\u03b8\u03b5\u03b9\u03ce\u03bd (4-2-2011). Publication: Paschou S, Voulgari PV, Vrabie IG, Saougou IG, Drosos AA. Fertility and reproduction in male patients with ankylosing spondylitis treated with infliximab. J Rheumatol 36: 351-354, 2009. Saougou I, Markatseli TE, Voulgari PV, Drosos AA. Maintained clinical response of infliximab treatment in ankylosing spondylitis: a 6-year long-term study. Joint Bone Spine 77: 325-9, 2010. Saougou I, Papagoras C, Markatseli TE, Voulgari PV, Drosos AA. A case report of a psoriatic arthritis patient on hemodialysis treated with tumor necrosis factor blocking agent and a literature review. Clin Rheumatol 29: 1455-1459, 2010. Saougou I, Markatseli TE, Papagoras C, Voulgari PV, Alamanos Y, Drosos AA. Sustained Clinical Response in Psoriatic Arthritis Patients Treated with Anti-TNF Agents: A 5-year Open-Label Observational Cohort Study. Semin Arthritis Rheum 2010 Sep 14. \u03a0\u03b1\u03c0\u03b1\u03b3\u03cc\u03c1\u03b1\u03c2 \u03a7\u03b1\u03c1\u03ac\u03bb\u03b1\u03bc\u03c0\u03bf\u03c2: \u039a\u03b1\u03c1\u03b4\u03b9\u03b1\u03b3\u03b3\u03b5\u03b9\u03b1\u03ba\u03cc\u03c2 \u03ba\u03af\u03bd\u03b4\u03c5\u03bd\u03bf\u03c2 \u03c3\u03b5 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u03c3\u03c0\u03bf\u03bd\u03b4\u03c5\u03bb\u03bf\u03b1\u03c1\u03b8\u03c1\u03bf\u03c0\u03ac\u03b8\u03b5\u03b9\u03b5\u03c2 (20-2-2013). Publication: Papagoras C, Drosos AA: Seronegative spondyloarthropathies: evolving concepts regarding diagnosis and treatment. J Spine 1: 1000e102, 2012. Drosos AA, Papagoras C: Cardiovascular disease in ankylosing spondylitis: another extra-skeletal feature of a chronic inflammatory disorder? J Spine 1: 1000e106, 2012. Papagoras C, Voulgari PV, Drosos AA: Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis. Clin Exp Rheumatol 2013 Feb 7. [Epub ahead of print]. Papagoras C, Markatseli TE, Saougou I, Alamanos Y, Zikou AK, Voulgari PV, Kiortsis DN, Drosos AA: Cardiovascular risk profile in patients with spondyloarthritis. Joint Bone Spine (in press) 2013. \u0395\u03c5\u03c1\u03b9\u03c0\u03af\u03b4\u03b7\u03c2 \u039a\u03b1\u03bb\u03c4\u03c3\u03bf\u03bd\u03bf\u03cd\u03b4\u03b7\u03c2: \u039d\u03b5\u03c5\u03c1\u03bf\u03bb\u03bf\u03b3\u03b9\u03ba\u03ad\u03c2 \u03b5\u03ba\u03b4\u03b7\u03bb\u03ce\u03c3\u03b5\u03b9\u03c2 \u03c4\u03c9\u03bd \u03b1\u03bd\u03c4\u03b9-TNF-\u03b1 \u03c0\u03b1\u03c1\u03b1\u03b3\u03cc\u03bd\u03c4\u03c9\u03bd \u03c3\u03b5 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u03c1\u03b5\u03c5\u03bc\u03b1\u03c4\u03bf\u03bb\u03bf\u03b3\u03b9\u03ba\u03ac \u03bd\u03bf\u03c3\u03ae\u03bc\u03b1\u03c4\u03b1 (15-12-2014). Publication: Kaltsonoudis E, Voulgari PV, Konitsiotis S, Drosos AA: Demyelination and other neurological adverse events after anti-TNF therapy. Autoimmun Rev 13: 54-58, 2014. Kaltsonoudis E, Zikou AK, Voulgari PV, Konitsiotis S, Argyropoulou MI, Drosos AA.Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study. Arthritis Res Ther 16: R125, 2014. \u039c\u03b9\u03c7\u03b1\u03ae\u03bb \u039c\u03af\u03b3\u03ba\u03bf\u03c2 (11-09-2017). \u03a0\u03b1\u03bd\u03b1\u03b3\u03b9\u03ce\u03c4\u03b7\u03c2 \u039c\u03c0\u03cc\u03b6\u03b9\u03bf\u03c2 (14-09-2017). \u03a7\u03c1\u03ae\u03c3\u03c4\u03bf\u03c2 \u03a0\u03b1\u03c0\u03b1\u03b4\u03cc\u03c0\u03bf\u03c5\u03bb\u03bf\u03c2 (21-09-2017). \u0391\u03bb\u03af\u03ba\u03b7 \u0392\u03b5\u03bd\u03b5\u03c4\u03c3\u03b1\u03bd\u03bf\u03c0\u03bf\u03cd\u03bb\u03bf\u03c5\u00a0 \u03a0\u03b1\u03c0\u03b1\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb \u0393\u03b5\u03ce\u03c1\u03b3\u03b9\u03bf\u03c2\u00a0<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_canvas","meta":{"footnotes":""},"class_list":["post-2327","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/rheumatology.gr\/en\/wp-json\/wp\/v2\/pages\/2327","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rheumatology.gr\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/rheumatology.gr\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/rheumatology.gr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rheumatology.gr\/en\/wp-json\/wp\/v2\/comments?post=2327"}],"version-history":[{"count":22,"href":"https:\/\/rheumatology.gr\/en\/wp-json\/wp\/v2\/pages\/2327\/revisions"}],"predecessor-version":[{"id":3454,"href":"https:\/\/rheumatology.gr\/en\/wp-json\/wp\/v2\/pages\/2327\/revisions\/3454"}],"wp:attachment":[{"href":"https:\/\/rheumatology.gr\/en\/wp-json\/wp\/v2\/media?parent=2327"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}